Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Axitinib × 30 days × Clear all

Phase

Status

Recruiting 4 Suspended 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Kidney Neoplasms 1 Carcinoma, Renal Cell 1

Interventions

Specimen Handling 30 Magnetic Resonance Spectroscopy 20 Biopsy 19 Cyclophosphamide 18 pembrolizumab 14 Carboplatin 13 Azacitidine 13 venetoclax 12 Paclitaxel 12 fludarabine 11 Gemcitabine 11 Drug Therapy 11 Standard of Care 10 Radiotherapy 10 Oxaliplatin 10 Nivolumab 10 Docetaxel 10 Cytarabine 10 Bevacizumab 10 Fluorouracil 8 Dexamethasone 8 Cisplatin 8 Injections 7 blinatumomab 6 X-Rays 6 Surgical Procedures, Operative 6 Radiosurgery 6 Leucovorin 6 Cetuximab 6 Capecitabine 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07123090 2026-02-27

SPARCC

Dana-Farber Cancer Institute

Phase 2 Not yet recruiting

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡